

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding antitumor immunity | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/5-2545/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/5-2545" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding antitumor immunity" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding antitumor immunity.">
            <meta name="og:description" content="Read the latest article version by Rodrigo Ramella Munhoz, Michael Andrew Postow, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="10074">
            <meta name="article-id" content="9356">
            <meta name="dc.title" content="Recent advances in understanding antitumor immunity">
            <meta name="dc.description" content="The term &ldquo;antitumor immunity&rdquo; refers to innate and adaptive immune responses which lead to tumor control. Turning the immune system into a destructive force against tumors has been achieved in a broad range of human cancers with the use of non-specific immunotherapies, vaccines, adoptive-cell therapy, and, more recently with significant success, through blockade of immune checkpoints. Nevertheless, the efficacy of these approaches is not universal, and tools to identify long-term responders and primarily refractory patients are warranted. In this article, we review recent advances in understanding the complex mechanisms of antitumor immunity and how these developments can be used to address open questions in a setting of growing clinical indications for the use of immunotherapy.">
            <meta name="dc.subject" content="antitumour immunity, immune response, tumour immunotherapies">
            <meta name="dc.creator" content="Munhoz, Rodrigo Ramella">
            <meta name="dc.creator" content="Postow, Michael Andrew">
            <meta name="dc.date" content="2016/10/20">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.9356.1">
            <meta name="dc.source" content="F1000Research 2016 5:2545">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="antitumour immunity">
            <meta name="prism.keyword" content=" immune response">
            <meta name="prism.keyword" content=" tumour immunotherapies">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2016/10/20">
            <meta name="prism.volume" content="5">
            <meta name="prism.number" content="2545">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.9356.1">
            <meta name="prism.url" content="https://f1000research.com/articles/5-2545">
            <meta name="citation_title" content="Recent advances in understanding antitumor immunity">
            <meta name="citation_abstract" content="The term &ldquo;antitumor immunity&rdquo; refers to innate and adaptive immune responses which lead to tumor control. Turning the immune system into a destructive force against tumors has been achieved in a broad range of human cancers with the use of non-specific immunotherapies, vaccines, adoptive-cell therapy, and, more recently with significant success, through blockade of immune checkpoints. Nevertheless, the efficacy of these approaches is not universal, and tools to identify long-term responders and primarily refractory patients are warranted. In this article, we review recent advances in understanding the complex mechanisms of antitumor immunity and how these developments can be used to address open questions in a setting of growing clinical indications for the use of immunotherapy.">
            <meta name="citation_description" content="The term &ldquo;antitumor immunity&rdquo; refers to innate and adaptive immune responses which lead to tumor control. Turning the immune system into a destructive force against tumors has been achieved in a broad range of human cancers with the use of non-specific immunotherapies, vaccines, adoptive-cell therapy, and, more recently with significant success, through blockade of immune checkpoints. Nevertheless, the efficacy of these approaches is not universal, and tools to identify long-term responders and primarily refractory patients are warranted. In this article, we review recent advances in understanding the complex mechanisms of antitumor immunity and how these developments can be used to address open questions in a setting of growing clinical indications for the use of immunotherapy.">
            <meta name="citation_keywords" content="antitumour immunity, immune response, tumour immunotherapies">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Rodrigo Ramella Munhoz">
            <meta name="citation_author_institution" content="Melanoma/Sarcoma Group, Oncology Center, Hospital S&iacute;rio Liban&ecirc;s, S&atilde;o Paulo, Brazil">
            <meta name="citation_author" content="Michael Andrew Postow">
            <meta name="citation_author_institution" content="Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA">
            <meta name="citation_author_institution" content="Weill Cornell Medical College, New York, NY, USA">
            <meta name="citation_publication_date" content="2016/10/20">
            <meta name="citation_volume" content="5">
            <meta name="citation_publication_number" content="2545">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.9356.1">
            <meta name="citation_firstpage" content="2545">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/5-2545/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/5-2545.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=10074 /> <input type=hidden id=articleId name=articleId value=9356 /> <input type=hidden id=xmlUrl value="/articles/5-2545/v1/xml"/> <input type=hidden id=xmlFileName value="-5-2545-v1.xml"> <input type=hidden id=article_uuid value=1a9746b7-3d3c-4874-a1fd-ec5589474bc1 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding antitumor immunity"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.9356.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.9356.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/5-2545"
  },
  "headline": "Recent advances in understanding antitumor immunity",
  "datePublished": "2016-10-20T16:35:49",
  "dateModified": "2016-10-20T16:35:49",
  "author": [
    {
      "@type": "Person",
      "name": "Rodrigo Ramella Munhoz"
    },    {
      "@type": "Person",
      "name": "Michael Andrew Postow"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The term &ldquo;antitumor immunity&rdquo; refers to innate and adaptive immune responses which lead to tumor control. Turning the immune system into a destructive force against tumors has been achieved in a broad range of human cancers with the use of non-specific immunotherapies, vaccines, adoptive-cell therapy, and, more recently with significant success, through blockade of immune checkpoints. Nevertheless, the efficacy of these approaches is not universal, and tools to identify long-term responders and primarily refractory patients are warranted. In this article, we review recent advances in understanding the complex mechanisms of antitumor immunity and how these developments can be used to address open questions in a setting of growing clinical indications for the use of immunotherapy."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/5-2545/v1",
            "name": "Recent advances in understanding antitumor immunity"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding antitumor immunity </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=10074 data-id=9356 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9356.1" data-recommended="" data-doi="10.12688/f1000research.9356.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/5-2545/v1/pdf?article_uuid=1a9746b7-3d3c-4874-a1fd-ec5589474bc1" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-9356-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-9356-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-9356-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Munhoz RR and Postow MA. Recent advances in understanding antitumor immunity [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2545 (<a class=new-orange href="https://doi.org/10.12688/f1000research.9356.1" target=_blank>https://doi.org/10.12688/f1000research.9356.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-9356-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=9356 id=track-article-signin-9356 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9356?target=/articles/5-2545/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10074 /> <input name=articleId type=hidden value=9356 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding antitumor immunity</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:rodrigo.rmunhoz@hsl.org.br" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rodrigo Ramella Munhoz</span></a><sup>1</sup>,&nbsp;</span><span class="">Michael Andrew Postow<sup>2,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:rodrigo.rmunhoz@hsl.org.br" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Rodrigo Ramella Munhoz</span></a><sup>1</sup>,&nbsp;</span><span class="">Michael Andrew Postow<sup>2,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 20 Oct 2016 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.9356.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Melanoma/Sarcoma Group, Oncology Center, Hospital S&iacute;rio Liban&ecirc;s, S&atilde;o Paulo, Brazil<br/> <sup>2</sup> Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA<br/> <sup>3</sup> Weill Cornell Medical College, New York, NY, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=17732-17128></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=17734-17129></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=17733-17130></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The term “antitumor immunity” refers to innate and adaptive immune responses which lead to tumor control. Turning the immune system into a destructive force against tumors has been achieved in a broad range of human cancers with the use of non-specific immunotherapies, vaccines, adoptive-cell therapy, and, more recently with significant success, through blockade of immune checkpoints. Nevertheless, the efficacy of these approaches is not universal, and tools to identify long-term responders and primarily refractory patients are warranted. In this article, we review recent advances in understanding the complex mechanisms of antitumor immunity and how these developments can be used to address open questions in a setting of growing clinical indications for the use of immunotherapy. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> antitumour immunity, immune response, tumour immunotherapies </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Rodrigo Ramella Munhoz (<a href="mailto:rodrigo.rmunhoz@hsl.org.br">rodrigo.rmunhoz@hsl.org.br</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Rodrigo Ramella Munhoz </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Rodrigo R. Munhoz has received honoraria from AstraZeneca, BMS, MSD, and Roche; has had an advisory role for Roche and MSD; and has received travel expenses from AstraZeneca, BMS, MSD, and Roche. Michael A. Postow has received honoraria from BMS and Merck; has had an advisory role for BMS and Amgen; and has received research funding from BMS. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Michael A. Postow has received research funding from BMS. <br/> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2016 Munhoz RR and Postow MA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Munhoz RR and Postow MA. Recent advances in understanding antitumor immunity [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2545 (<a href="https://doi.org/10.12688/f1000research.9356.1" target=_blank>https://doi.org/10.12688/f1000research.9356.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 20 Oct 2016, <b>5</b>(F1000 Faculty Rev):2545 (<a href="https://doi.org/10.12688/f1000research.9356.1" target=_blank>https://doi.org/10.12688/f1000research.9356.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 20 Oct 2016, <b>5</b>(F1000 Faculty Rev):2545 (<a href="https://doi.org/10.12688/f1000research.9356.1" target=_blank>https://doi.org/10.12688/f1000research.9356.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d22327e176>Introduction</h2><p class="" id=d22327e179>Using the immune system to fight cancer has been confirmed as one of the major breakthroughs in oncology, yielding the possibility of long-term clinical benefit and prolonged survival. Despite the recent advances with immune checkpoint-directed approaches, the concept of “immunotherapy” dates back to the 19<sup>th</sup> and early 20<sup>th</sup> century with Wilhelm Busch, William B. Coley, and Paul Ehrlich and comprises distinct strategies, including vaccines, non-specific cytokines, and adoptive cell therapies<sup><a href="#ref-1">1</a></sup>. The introduction of monoclonal antibodies targeting co-receptors of immune activation resulted in unprecedented benefits in the management of distinct malignancies, with exceptional results in melanoma, renal cell carcinoma, Merkel cell carcinoma, lung cancer, urothelial carcinoma, and other neoplasms<sup><a href="#ref-2">2</a>–<a href="#ref-7">7</a></sup>.</p><p class="" id=d22327e199>Nevertheless, despite the certainties already available that are redefining the landscape of cancer treatment, several questions emerged to daunt clinicians and scientists: how do we select the best candidates for therapy? What factors are involved in primary and acquired resistance? What are the best biomarkers to guide treatment decisions and rationalize costs? How do we pick the best combinations to optimize outcomes?</p><p class="" id=d22327e202>Elucidating the mechanisms regulating the interactions between the immune system and cancer cells is critical in order to provide tools to address the growing number of open questions, overcome resistance, and broaden the benefits of immunotherapy to more patients.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22327e208>The tumor-host immune system interaction and role of co-receptors</h2><p class="" id=d22327e211>The immune system can be activated by tumor antigens and, once primed, can elicit an antitumor response which in some cases can result in tumor destruction. Unfortunately, the successful development of antitumor immunity is often hampered by a plethora of factors that can directly determine the adequacy of the immune response. The singular event illustrated by a cytotoxic lymphocyte interacting with a tumor cell holds a background of a series of complex mechanisms, encompassed under the concepts of “immunosurveillance” and “immunoediting”<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Critical aspects in the tumor–immune system interface include the processing and presentation of released antigens by antigen-presenting cells (APCs), interaction with T lymphocytes, subsequent immune/T-cell activation, trafficking of antigen-specific effector cells, and, ultimately, the engagement of the target tumor cell by the activated effector T cell<sup><a href="#ref-10">10</a>,<a href="#ref-11">11</a></sup>. Nevertheless, although often successful in preventing tumor outgrowth, this “cancer-immunity cycle” can be disrupted by artifices involved in immune escape and development of tolerance, culminating with the evasion and proliferation of malignant cells<sup><a href="#ref-9">9</a>–<a href="#ref-11">11</a></sup>.</p><p class="" id=d22327e235>T-cell activation relies on the interaction of the T-cell receptor with antigens presented as peptides through the major histocompatibility complex (MHC) by the APC. Tumor antigens are classified as tumor-specific antigens (TSAs), derived from cancer-germline genes, point mutations or oncogenic viruses and unique to tumor cells, or tumor-associated antigens (TAAs), which include differentiation antigens (tyrosinase, gp100, Melan-A/MART-1, carcinoembryonic antigen, prostate-specific antigen, prostatic acidic phosphatase, etc.) and peptides associated with genes overexpressed in tumors (survivin, erbB-2 or CD340, RAGE-1, PRAME, and WT1)<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. HLA downregulation has been shown to result in decreased antigenicity and therefore acts as a mechanism of immune evasion<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d22327e249>While the recognition of peptide–MHC by the TCR plays a central role in the process of T-cell-mediated immunity, additional cell-surface co-receptors are mandatory for the modulation of the immune response, either positively or negatively<sup><a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup>. Two of these inhibitory co-receptors, called immune checkpoints, are involved in adaptive immune resistance and T-cell tolerance and have been exploited clinically with the development of checkpoint-blocking monoclonal antibodies. The two receptors include the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4, also known as CD152) and the programmed cell death receptor 1 (PD-1 or CD279) and its ligand (PD-L1, also named CD274 or B7-H1)<sup><a href="#ref-16">16</a></sup>. Additional inhibitory receptors include B- and T-cell attenuator (BTLA or CD272), lymphocyte-activation protein 3 (LAG-3 or CD223), T-cell immunoglobulin and mucin protein-3 (TIM-3, also termed hepatitis A virus cellular receptor 2 – HAVCR2 – or CD366), and V-domain immunoglobulin-containing suppressor of T-cell activation (VISTA, B7H5, or programmed death 1 homolog – PD-1H)<sup><a href="#ref-16">16</a>–<a href="#ref-18">18</a></sup>. Also potential targets for therapeutic manipulation, co-stimulatory receptors associated with positive modulation of the immune synapse include CD27, CD28, CD137, inducible T-cell costimulator (ICOS or CD278), herpesvirus entry mediator (HVEM, also known as tumor necrosis factor receptor superfamily member 14 – TNFRSF14), and glucocorticoid-induced TNFR-related protein (GITR or tumor necrosis factor receptor superfamily member 18 – TNFRSF18). It is important to highlight, however, that the list of co-receptors and ligands encompasses both co-inhibitory and co-stimulatory molecules other than those aforementioned, some of which are not fully characterized.</p><p class="" id=d22327e270>The mobilization of these components of the adaptive immune system involved in antitumor immunity, including CD4+ helper T cells and CD8+ effector T cells, are largely influenced by a milieu of variables that involve intrinsic tumor characteristics, microenvironment factors, and genetic/epigenetic determinants<sup><a href="#ref-19">19</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22327e280>Tumor antigenic potential</h2><p class="" id=d22327e283>Antigens are paramount in immune responses mediated by T cells; indeed, histologies that served as proofs of concept for the development of immunotherapy, including melanoma and renal cell carcinoma, have long been characterized as potentially “immunogenic” or “antigenic”<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>. Antigen-directed T-cell activation can result from the presentation of tumor self-peptides or peptides/neoantigens that emerge from aberrant gene products. As a consequence, the tumor genomic landscape or mutational load would represent a logical surrogate of the immunogenicity or “foreignness” of distinct malignancies through the generation of neoepitopes<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>.</p><p class="" id=d22327e300>Indeed, prolonged patient survival has been associated with an increased number of somatic missense mutations and mutational epitopes<sup><a href="#ref-23">23</a></sup>. More importantly, a correlation between the mutational burden and clinical benefit has been seen in the setting of immune-checkpoint blockade<sup><a href="#ref-24">24</a>–<a href="#ref-26">26</a></sup>. Snyder <i>et al</i>. was able to demonstrate an association between outcomes following anti-CTLA-4 therapy in melanoma and a high mutational load. Of note, although a high mutational load increased the probability of an “immunogenic” neoepitope signature, these variables were not completely overlapping. An even more intriguing finding was that candidate neoepitopes were homologous to distinct viral and bacterial antigens<sup><a href="#ref-24">24</a></sup>. Some similar findings were reported by Van Allen and colleagues based on an expanded cohort of 110 patients with metastatic melanoma; using transcriptome data, a correlation among the expression of cytolytic genes, neoantigen load, and clinical benefit to CTLA-4 was also demonstrated<sup><a href="#ref-25">25</a></sup>.</p><p class="" id=d22327e325>The mutational landscape was also found to be a determinant of clinical benefit from PD-1 blockade in patients with non-small-cell lung cancer (NSCLC); moreover, responses were more frequent in the setting of environmental exposure to tobacco, determined using a molecular signature of smoking that also correlated with a higher number of non-synonymous mutations<sup><a href="#ref-26">26</a></sup>. Serving as a strong proof of principle, blockade of PD-1 resulted in clinically meaningful activity in patients with mismatch repair (MMR) deficiency-associated tumors<sup><a href="#ref-27">27</a></sup>, characterized by a large number of somatic mutations and rich in expression of immune inhibitors (PD-1, PD-L1, LAG-3, and indoleamine 2,3 dioxygenase [IDO])<sup><a href="#ref-28">28</a></sup>. Nevertheless, the correlation among mutational burden, the generation of neoantigens/neoepitopes, and the activation of antigen-specific T cells is not linear and neoepitopes may not be universally presented by the MHC<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Some studies have also suggested that mutational load may be prognostic but not necessarily predictive for responses to PD-1 therapy in melanoma<sup><a href="#ref-31">31</a></sup>. In addition, while clonal neoantigens may drive CD8+ T-cell responses and predict responses to PD-1 and CTLA-4 blockade, the clinical impact of subclonal mutations is largely debatable and arguably marginal, despite being associated with increased mutational load<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d22327e356>Albeit intuitive, the tumor antigenic potential is not driven solely by the total mutational load, as other antigens can also be immunogenic. Additional insults to the DNA other than the number of mutations can result in potentially neoantigenic epitopes, and oncogenic viruses could be determinant in the cancer–host immune system interaction and antigenicity. In Merkel cell carcinoma, the presence of Merkel cell polyomavirus (MCPyV) DNA and tumor-infiltrating lymphocytes and the expression of PD-L1 support the existence of intrinsic antitumor immunity<sup><a href="#ref-33">33</a></sup>. Indeed, PD-1 blockade resulted in meaningful clinical activity in Merkel cell carcinoma patients, particularly in those associated with MCPyV, despite a lower mutational burden in this subgroup<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d22327e368>While most studies have investigated the mutational profile of tumors as a surrogate for “tumor antigenicity” as a potential pre-treatment biomarker of responsiveness to checkpoint blockade, a recent study specifically examined the mutational profile of resistant lesions that arose in patients with melanoma who previously benefitted from PD-1 therapy. Although the number of patients examined in this series was small (n=4), some secondary resistant lesions had mutations in the interferon (IFN) (JAK mutations) and antigen-presentation (beta-2-microglobulin) pathways, suggesting possible mechanisms of immune escape from PD-1<sup><a href="#ref-34">34</a></sup>. Additional study in larger patient cohorts would be of value.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22327e378>Tumor microenvironment factors and pre-existing host immune conditions</h2><p class="" id=d22327e381>Despite the central role of intrinsic antigenicity, tumor immunogenicity is directly influenced by a plethora of immunomodulatory factors co-existing in the tumor microenvironment that derive from both tumor cells and host cells. Also intuitive, the concept that “inflamed” or “hot” tumors may derive greater benefit from immunotherapy is supported by mounting evidence.</p><p class="" id=d22327e384>The characterization of the T-cell infiltrate has been associated with both innate antitumor immunity and benefit from immune-checkpoint blockade. The density of antigen-specific effector T cells within the tumor microenvironment and invasive margin is a predictor of survival in patients with colorectal cancer, and the concept that pre-treatment adaptive immune responses and immune infiltrates directly influence the natural course of different malignancies is consistent across different studies<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. Pre-existing CD8+ T cells located at the invasive tumor margin are aligned with expression of PD-1 and PD-L1<sup><a href="#ref-37">37</a></sup>. Additionally, increased CD8+ T-cell infiltrates within the tumor microenvironment directly correlated with benefit from PD-1 blockade<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. An association between absolute lymphocyte count in the peripheral blood of patients who received anti-CTLA-4 therapy and clinical benefit has also been shown as an increase in lymphocyte count during treatment or at baseline<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>. Also, anti-CTLA-4 treatment was demonstrated to result in newly detected CD8+ T-cell responses measured in post-treatment samples, suggesting that CTLA-4 blockade has a direct role in increasing T-cell priming<sup><a href="#ref-41">41</a></sup>.</p><p class="" id=d22327e416>Increased levels of IFN-γ and expression of ICOS on peripheral lymphocytes and tumor-infiltrating lymphocytes has been demonstrated in the setting of CTLA-4 blockade<sup><a href="#ref-42">42</a></sup>, providing the rationale for additional combined approaches. CD4+ T cells with increased ICOS expression also correlated with an increase in effector/regulatory T-cell ratio<sup><a href="#ref-43">43</a></sup>.</p><p class="" id=d22327e427>Factors involved in the modulation of the tumor and immune microenvironment are also crucial in understanding the tumor–host immune system interaction. In metastatic melanoma samples, cell lines, and xenografts, T-cell and macrophage recruitment occurred more frequently in association with the expression of a subset of chemokines (CCL2, CCL3, CCL4, CCL5, CXCL9, and CXCL10) associated with an “inflamed” phenotype<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. Indeed, CXCL9 and CXCL10, ligands of CXCR3, were incorporated in a gene signature associated with responses to anti-PD-1 treatment and indicative of an inflamed microenvironment<sup><a href="#ref-46">46</a></sup>. Similarly, the presence of tumor-reactive cells correlated with endogenous accumulation of type I IFNs (IFN-α, IFN-β, IFN-ε, IFN-κ, and IFN-ω)<sup><a href="#ref-47">47</a></sup>. In a topic of significant clinical relevance, the regulation of genes associated with IFN signaling was achieved with the use of azacitidine, a DNA methyltransferase inhibitor, through the epigenetic regulation of gene promoters normally silenced<sup><a href="#ref-48">48</a></sup>.</p><p class="" id=d22327e450>Nevertheless, T-cell infiltration is also accompanied by the induction of tolerance mechanisms largely involved in the abrogation of an effective antitumor immune response. These so-called inhibitory pathways involve the expression of IDO and PD-L1, induced by IFN-γ, and recruitment of FoxP3+CD4+ (regulatory T) cells through CCL22 in the setting of CD8+ T-cell activation<sup><a href="#ref-49">49</a></sup>.</p><p class="" id=d22327e457>In melanoma lesions and other malignancies, the expression of PD-L1 has been associated with the presence of tumor-infiltrating lymphocytes, IFN-γ expression, and improved survival in some studies<sup><a href="#ref-33">33</a>,<a href="#ref-50">50</a>–<a href="#ref-52">52</a></sup>. While straightforward, using the expression of PD-L1 as a biomarker poses a series of caveats and uncertainties. PD-L1 is expressed in macrophages and, in the setting of immune activation, in B, T, myeloid, and dendritic cells (DCs) as well as in non-hematopoietic and endothelial cells<sup><a href="#ref-53">53</a></sup>. Indeed, the early clinical development of anti-PD-1 agents already suggested that tumors rich in PD-L1 expression were more likely to respond to therapy<sup><a href="#ref-54">54</a></sup>, although this correlation is imperfect. It is important to emphasize that PD-L1 expression occurs along a spectrum of positivity and is dynamic and heterogeneous between and within tumors. The expression of PD-L1 can occur constitutively, or it can be induced upon T-cell activation<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a>,<a href="#ref-55">55</a></sup>. In addition to analytical technical issues detecting PD-L1, pre-testing factors (distribution, cell population by which PD-L1 is expressed, etc.) and intrapatient, intertumor heterogeneity pose significant limitations to the interpretation of PD-L1 expression<sup><a href="#ref-56">56</a></sup>.</p><p class="" id=d22327e492>Similarly, the expansion of regulatory T cells and myeloid-derived suppressor cells (MDSCs) also represents a mechanism of immune escape, suggesting that additional immunosuppressive factors may need to be targeted to increase antitumor immunity. In murine models, inhibition of MDSC trafficking by CXCR2 deficiency or CXCR2 signaling blockade increased the efficacy of anti-PD-1 therapy<sup><a href="#ref-57">57</a></sup>. It has been demonstrated in pre-clinical models that inhibition of regulatory T cells may be necessary for anti-CTLA-4-induced antitumor activity<sup><a href="#ref-58">58</a></sup>. Moreover, the efficacy of anti-CTLA-4 therapy has been associated with regulatory T-cell depletion in the presence of Fcγ receptor-expressing macrophages, suggesting that the mechanisms involved in immune activation may be more diverse than anticipated<sup><a href="#ref-59">59</a></sup>.</p><p class="" id=d22327e507>In addition to the aforementioned factors related to pre-existing immune conditions and regulation within the tumor microenvironment, antitumor immunity can also be affected by a very particular variable: the host microbiota. Across different studies, intestinal commensal bacteria have been shown to influence T-cell differentiation, APC activation, and antitumor immunity modulation<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>. In a demonstration of this principle, fecal material transfer between two murine populations resulted in infiltration of tumor-specific CD8+ T cells and delayed tumor growth, an effect attributed to the colonization by Bifidobacterium species. Of note, in addition to innate antitumor immunity, oral administration of Bifidobacterium also potentiated the antitumor effect of PD-L1 blockade<sup><a href="#ref-62">62</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22327e524>Genetic, epigenetic, and signaling modulators of the immune response</h2><p class="" id=d22327e527>If it is now well established that immune responses can be influenced by genomic correlates, including the burden of non-synonymous mutations, emerging evidence suggests that specific genetic variables are also involved in direct modulation of antitumor immunity.</p><p class="" id=d22327e530>Distinct somatic mutations have been shown to be related to intratumoral immunity. As an example, restoration of p53 signaling has been associated with the activation of tumor-directed innate immune cells, natural killer cell recruitment, and chemokine production<sup><a href="#ref-63">63</a>,<a href="#ref-64">64</a></sup>. Another study showed a low mutational burden was associated with PD-L1 negativity and worse survival<sup><a href="#ref-65">65</a></sup>. In melanoma cell lines, disruptive mutations of JAK1 or JAK2 (downstream elements of IFN signaling) have been shown to abrogate PD-L1 expression upon exposure to IFN-γ, suggesting a mechanism for innate resistance to PD-1 blockade<sup><a href="#ref-66">66</a></sup>. In NSCLC samples, expression of PD-L1 and PD-L1 gene amplification correlated with simultaneous amplification of JAK2, whereas JAK2 inhibition resulted in reduced expression of PD-L1 protein<sup><a href="#ref-67">67</a></sup>. Conversely, PI3K-AKT pathway activation resulting from PTEN loss has been shown to correlate with immunoresistance mediated by PD-L1 and PD-L2 expression in preclinical models as well as in a clinical series<sup><a href="#ref-55">55</a>,<a href="#ref-68">68</a></sup>. An immune translation of somatic events has also been reported for aberrations involving STAT3/ALK signaling and EGFR mutations<sup><a href="#ref-69">69</a>,<a href="#ref-70">70</a></sup>. In melanoma metastases, mutations involved in activation of the WNT/β-catenin pathway were associated with a non-T-cell inflamed phenotype and T-cell exclusion from the tumor microenvironment<sup><a href="#ref-71">71</a></sup>.</p><p class="" id=d22327e571>Besides T-cell activation, DC mobilization can be modulated by distinct genetic pathways involved in innate immune sensing of immunogenic tumors. As an example, knockout mice deficient for the transcription factor Batf3, involved in DC recruitment and activation through type I IFNs, show impaired CD8+ T-cell activation<sup><a href="#ref-72">72</a></sup>. As a corollary, tumor-infiltrating DCs can be artificially manipulated in order to induce antitumor immunity, as demonstrated in preclinical models in which intratumoral delivery of mRNA involved in the activation of cross-presenting DCs resulted in T-cell responses<sup><a href="#ref-73">73</a></sup>. Similarly, defective spontaneous T-cell priming has been demonstrated in models lacking the cytosolic receptor stimulator of IFN genes complex (STING), which is involved in type I IFN and proinflammatory cytokine responses. In line with these observations, vaccines with STING ligands were able to induce DCs, PD-L1 upregulation, and antigen-specific T-cell activation in preclinical models<sup><a href="#ref-74">74</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d22327e590>Conclusions</h2><p class="" id=d22327e593>It is well known that the characterization of basic mechanisms underlying antitumor immunity has paved the way for the development of therapeutic strategies to manipulate antitumor immunity for favorable patient benefit. The interplay among different factors driving the tumor–host immune response is not fully characterized, and the complexity of these factors has been summarized by Blank and colleagues as the “cancer immunogram”<sup><a href="#ref-75">75</a></sup>. The understanding of these multiple regulatory pathways involved in antitumor immunity is crucial not only for patient selection and therapeutic decisions but also for improving outcomes through combined approaches. In addition, despite the significant clinical results and survival improvements seen in patients with some cancers, primary and acquired/secondary resistance to immunotherapy remain challenges. Future research will be critical in addressing the large body of questions which remains to be answered.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d22327e1 class=n-a></a><h2 class=main-title id=d22568>Competing interests</h2><p class=metadata-entry><a name=d22327e111 class=n-a></a><p id=d22327e113> Rodrigo R. Munhoz has received honoraria from AstraZeneca, BMS, MSD, and Roche; has had an advisory role for Roche and MSD; and has received travel expenses from AstraZeneca, BMS, MSD, and Roche. Michael A. Postow has received honoraria from BMS and Merck; has had an advisory role for BMS and Amgen; and has received research funding from BMS.</p></p></div><div class=back-section><a name=d22327e1 class=n-a></a><h2 class=main-title id=d22570>Grant information</h2><p>Michael A. Postow has received research funding from BMS.</p></div><div class=back-section><a name=d22327e604 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d22841>References</h2><div class="section ref-list"><a name=d22327e604 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d22327e611 class=n-a></a>Curiel TJ: Historical perspectives and current trends in cancer immunotherapy. In: <i>Cancer Immunotherapy: Paradigms, Practice and Promise</i>. Curiel TJ (Ed.). Springer; New York, NY USA, 2012. <a target=xrefwindow id=d22327e616 href="http://dx.doi.org/10.1007/978-1-4614-4732-0_1">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/4128956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e625 class=n-a></a>Hodi FS, O'Day SJ, McDermott DF, <i> et al.</i>: Improved survival with ipilimumab in patients with metastatic melanoma. <i>N Engl J Med.</i> 2010; <b>363</b>(8): 711–23. <a target=xrefwindow id=d22327e636 href="http://www.ncbi.nlm.nih.gov/pubmed/20525992">PubMed Abstract </a> | <a target=xrefwindow id=d22327e639 href="http://dx.doi.org/10.1056/NEJMoa1003466">Publisher Full Text </a> | <a target=xrefwindow id=d22327e643 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3549297">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/4128956">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725813702"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e656 class=n-a></a>Borghaei H, Paz-Ares L, Horn L, <i> et al.</i>: Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. <i>N Engl J Med.</i> 2015; <b>373</b>(17): 1627–39. <a target=xrefwindow id=d22327e667 href="http://www.ncbi.nlm.nih.gov/pubmed/26412456">PubMed Abstract </a> | <a target=xrefwindow id=d22327e670 href="http://dx.doi.org/10.1056/NEJMoa1507643">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725813702">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726295412"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e683 class=n-a></a>Nghiem PT, Bhatia S, Lipson EJ, <i> et al.</i>: PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma. <i>N Engl J Med.</i> 2016; <b>374</b>(26): 2542–52. <a target=xrefwindow id=d22327e694 href="http://www.ncbi.nlm.nih.gov/pubmed/27093365">PubMed Abstract </a> | <a target=xrefwindow id=d22327e697 href="http://dx.doi.org/10.1056/NEJMoa1603702">Publisher Full Text </a> | <a target=xrefwindow id=d22327e701 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4927341">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726295412">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726204768"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e714 class=n-a></a>Rosenberg JE, Hoffman-Censits J, Powles T, <i> et al.</i>: Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. <i>Lancet.</i> 2016; <b>387</b>(10031): 1909–20. <a target=xrefwindow id=d22327e725 href="http://www.ncbi.nlm.nih.gov/pubmed/26952546">PubMed Abstract </a> | <a target=xrefwindow id=d22327e728 href="http://dx.doi.org/10.1016/S0140-6736(16)00561-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726204768">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725238474"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e742 class=n-a></a>Robert C, Long GV, Brady B, <i> et al.</i>: Nivolumab in previously untreated melanoma without <i>BRAF</i> mutation. <i>N Engl J Med.</i> 2015; <b>372</b>(4): 320–30. <a target=xrefwindow id=d22327e756 href="http://www.ncbi.nlm.nih.gov/pubmed/25399552">PubMed Abstract </a> | <a target=xrefwindow id=d22327e760 href="http://dx.doi.org/10.1056/NEJMoa1412082">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725238474">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725442696"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e773 class=n-a></a>Robert C, Schachter J, Long GV, <i> et al.</i>: Pembrolizumab versus Ipilimumab in Advanced Melanoma. <i>N Engl J Med.</i> 2015; <b>372</b>(6): 2521–32. <a target=xrefwindow id=d22327e784 href="http://www.ncbi.nlm.nih.gov/pubmed/25891173">PubMed Abstract </a> | <a target=xrefwindow id=d22327e787 href="http://dx.doi.org/10.1056/NEJMoa1503093">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725442696">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d22327e800 class=n-a></a>Burnet FM: The concept of immunological surveillance. <i>Prog Exp Tumor Res.</i> 1970; <b>13</b>: 1–27. <a target=xrefwindow id=d22327e808 href="http://www.ncbi.nlm.nih.gov/pubmed/4921480">PubMed Abstract </a> | <a target=xrefwindow id=d22327e811 href="http://dx.doi.org/10.1159/000386035">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d22327e820 class=n-a></a>Dunn GP, Bruce AT, Ikeda H, <i> et al.</i>: Cancer immunoediting: from immunosurveillance to tumor escape. <i>Nat Immunol.</i> 2002; <b>3</b>(11): 991–8. <a target=xrefwindow id=d22327e831 href="http://www.ncbi.nlm.nih.gov/pubmed/12407406">PubMed Abstract </a> | <a target=xrefwindow id=d22327e834 href="http://dx.doi.org/10.1038/ni1102-991">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/9499956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e843 class=n-a></a>Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. <i>Cell.</i> 2011; <b>144</b>(5): 646–74. <a target=xrefwindow id=d22327e851 href="http://www.ncbi.nlm.nih.gov/pubmed/21376230">PubMed Abstract </a> | <a target=xrefwindow id=d22327e854 href="http://dx.doi.org/10.1016/j.cell.2011.02.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/9499956">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d22327e867 class=n-a></a>Chen DS, Mellman I: Oncology meets immunology: the cancer-immunity cycle. <i>Immunity.</i> 2013; <b>39</b>(1): 1–10. <a target=xrefwindow id=d22327e875 href="http://www.ncbi.nlm.nih.gov/pubmed/23890059">PubMed Abstract </a> | <a target=xrefwindow id=d22327e878 href="http://dx.doi.org/10.1016/j.immuni.2013.07.012">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d22327e888 class=n-a></a>van der Bruggen P, Traversari C, Chomez P, <i> et al.</i>: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. <i>Science.</i> 1991; <b>254</b>(5038): 1643–7. <a target=xrefwindow id=d22327e899 href="http://www.ncbi.nlm.nih.gov/pubmed/1840703">PubMed Abstract </a> | <a target=xrefwindow id=d22327e902 href="http://dx.doi.org/10.1126/science.1840703">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d22327e911 class=n-a></a>Vigneron N: Human Tumor Antigens and Cancer Immunotherapy. <i>Biomed Res Int.</i> 2015; <b>2015</b>: 948501. <a target=xrefwindow id=d22327e919 href="http://www.ncbi.nlm.nih.gov/pubmed/26161423">PubMed Abstract </a> | <a target=xrefwindow id=d22327e922 href="http://dx.doi.org/10.1155/2015/948501">Publisher Full Text </a> | <a target=xrefwindow id=d22327e925 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4487697">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d22327e934 class=n-a></a>Shukla SA, Rooney MS, Rajasagi M, <i> et al.</i>: Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. <i>Nat Biotechnol.</i> 2015; <b>33</b>(11): 1152–8. <a target=xrefwindow id=d22327e945 href="http://www.ncbi.nlm.nih.gov/pubmed/26372948">PubMed Abstract </a> | <a target=xrefwindow id=d22327e948 href="http://dx.doi.org/10.1038/nbt.3344">Publisher Full Text </a> | <a target=xrefwindow id=d22327e952 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4747795">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d22327e961 class=n-a></a>Greenwald RJ, Freeman GJ, Sharpe AH: The B7 family revisited. <i>Annu Rev Immunol.</i> 2005; <b>23</b>: 515–48. <a target=xrefwindow id=d22327e969 href="http://www.ncbi.nlm.nih.gov/pubmed/15771580">PubMed Abstract </a> | <a target=xrefwindow id=d22327e972 href="http://dx.doi.org/10.1146/annurev.immunol.23.021704.115611">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d22327e981 class=n-a></a>Pardoll DM: The blockade of immune checkpoints in cancer immunotherapy. <i>Nat Rev Cancer.</i> 2012; <b>12</b>(4): 252–64. <a target=xrefwindow id=d22327e989 href="http://www.ncbi.nlm.nih.gov/pubmed/22437870">PubMed Abstract </a> | <a target=xrefwindow id=d22327e992 href="http://dx.doi.org/10.1038/nrc3239">Publisher Full Text </a> | <a target=xrefwindow id=d22327e995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4856023">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d22327e1004 class=n-a></a>Lines JL, Sempere LF, Broughton T, <i> et al.</i>: VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy. <i>Cancer Immunol Res.</i> 2014; <b>2</b>(6): 510–7. <a target=xrefwindow id=d22327e1015 href="http://www.ncbi.nlm.nih.gov/pubmed/24894088">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1018 href="http://dx.doi.org/10.1158/2326-6066.CIR-14-0072">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1022 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4085258">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d22327e1032 class=n-a></a>Mellman I, Coukos G, Dranoff G: Cancer immunotherapy comes of age. <i>Nature.</i> 2011; <b>480</b>(7378): 480–9. <a target=xrefwindow id=d22327e1040 href="http://www.ncbi.nlm.nih.gov/pubmed/22193102">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1043 href="http://dx.doi.org/10.1038/nature10673">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1046 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3967235">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d22327e1055 class=n-a></a>Blankenstein T, Coulie PG, Gilboa E, <i> et al.</i>: The determinants of tumour immunogenicity. <i>Nat Rev Cancer.</i> 2012; <b>12</b>(4): 307–13. <a target=xrefwindow id=d22327e1066 href="http://www.ncbi.nlm.nih.gov/pubmed/22378190">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1069 href="http://dx.doi.org/10.1038/nrc3246">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1073 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3552609">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d22327e1082 class=n-a></a>Alexandrov LB, Nik-Zainal S, Wedge DC, <i> et al.</i>: Signatures of mutational processes in human cancer. <i>Nature.</i> 2013; <b>500</b>(7463): 415–21. <a target=xrefwindow id=d22327e1093 href="http://www.ncbi.nlm.nih.gov/pubmed/23945592">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1096 href="http://dx.doi.org/10.1038/nature12477">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1100 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3776390">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13945987"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1109 class=n-a></a>Matsushita H, Vesely MD, Koboldt DC, <i> et al.</i>: Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. <i>Nature.</i> 2012; <b>482</b>(7385): 400–4. <a target=xrefwindow id=d22327e1120 href="http://www.ncbi.nlm.nih.gov/pubmed/22318521">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1123 href="http://dx.doi.org/10.1038/nature10755">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1127 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3874809">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13945987">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d22327e1140 class=n-a></a>van Rooij N, van Buuren MM, Philips D, <i> et al.</i>: Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma. <i>J Clin Oncol.</i> 2013; <b>31</b>(32): e439–42. <a target=xrefwindow id=d22327e1151 href="http://www.ncbi.nlm.nih.gov/pubmed/24043743">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1154 href="http://dx.doi.org/10.1200/JCO.2012.47.7521">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1158 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3836220">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718369754"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1167 class=n-a></a>Brown SD, Warren RL, Gibb EA, <i> et al.</i>: Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival. <i>Genome Res.</i> 2014; <b>24</b>(5): 743–50. <a target=xrefwindow id=d22327e1178 href="http://www.ncbi.nlm.nih.gov/pubmed/24782321">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1181 href="http://dx.doi.org/10.1101/gr.165985.113">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1185 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4009604">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718369754">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725241175"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1199 class=n-a></a>Snyder A, Makarov V, Merghoub T, <i> et al.</i>: Genetic basis for clinical response to CTLA-4 blockade in melanoma. <i>N Engl J Med.</i> 2014; <b>371</b>(23): 2189–99. <a target=xrefwindow id=d22327e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/25409260">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1213 href="http://dx.doi.org/10.1056/NEJMoa1406498">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1217 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4315319">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725241175">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725780109"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1230 class=n-a></a>van Allen EM, Miao D, Schilling B, <i> et al.</i>: Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. <i>Science.</i> 2015; <b>350</b>(6257): 207–11. <a target=xrefwindow id=d22327e1241 href="http://www.ncbi.nlm.nih.gov/pubmed/26359337">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1244 href="http://dx.doi.org/10.1126/science.aad0095">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1248 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5054517">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725780109">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725388762"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1261 class=n-a></a>Rizvi NA, Hellmann MD, Snyder A, <i> et al.</i>: Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. <i>Science.</i> 2015; <b>348</b>(6230): 124–8. <a target=xrefwindow id=d22327e1272 href="http://www.ncbi.nlm.nih.gov/pubmed/25765070">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1275 href="http://dx.doi.org/10.1126/science.aaa1348">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1279 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4993154">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725388762">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725528363"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1292 class=n-a></a>Le DT, Uram JN, Wang H, <i> et al.</i>: PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. <i>N Engl J Med.</i> 2015; <b>372</b>(26): 2509–20. <a target=xrefwindow id=d22327e1303 href="http://www.ncbi.nlm.nih.gov/pubmed/26028255">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1306 href="http://dx.doi.org/10.1056/NEJMoa1500596">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4481136">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725528363">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d22327e1323 class=n-a></a>Llosa NJ, Cruise M, Tam A, <i> et al.</i>: The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. <i>Cancer Discov.</i> 2015; <b>5</b>(1): 43–51. <a target=xrefwindow id=d22327e1334 href="http://www.ncbi.nlm.nih.gov/pubmed/25358689">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1337 href="http://dx.doi.org/10.1158/2159-8290.CD-14-0863">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1341 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4293246">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d22327e1350 class=n-a></a>Yadav M, Jhunjhunwala S, Phung QT, <i> et al.</i>: Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. <i>Nature.</i> 2014; <b>515</b>(7528): 572–6. <a target=xrefwindow id=d22327e1361 href="http://www.ncbi.nlm.nih.gov/pubmed/25428506">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1364 href="http://dx.doi.org/10.1038/nature14001">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d22327e1374 class=n-a></a>Tran E, Ahmadzadeh M, Lu YC, <i> et al.</i>: Immunogenicity of somatic mutations in human gastrointestinal cancers. <i>Science.</i> 2015; <b>350</b>(6266): 1387–90. <a target=xrefwindow id=d22327e1385 href="http://www.ncbi.nlm.nih.gov/pubmed/26516200">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1388 href="http://dx.doi.org/10.1126/science.aad1253">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726187695"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1397 class=n-a></a>McGranahan N, Furness AJ, Rosenthal R, <i> et al.</i>: Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. <i>Science.</i> 2016; <b>351</b>(6280): 1463–9. <a target=xrefwindow id=d22327e1408 href="http://www.ncbi.nlm.nih.gov/pubmed/26940869">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1411 href="http://dx.doi.org/10.1126/science.aaf1490">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1415 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984254">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726187695">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726228392"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1428 class=n-a></a>Hugo W, Zaretsky JM, Sun L, <i> et al.</i>: Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma. <i>Cell.</i> 2016; <b>165</b>(1): 35–44. <a target=xrefwindow id=d22327e1439 href="http://www.ncbi.nlm.nih.gov/pubmed/26997480">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1442 href="http://dx.doi.org/10.1016/j.cell.2016.02.065">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808437">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726228392">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d22327e1459 class=n-a></a>Lipson EJ, Vincent JG, Loyo M, <i> et al.</i>: PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival. <i>Cancer Immunol Res.</i> 2013; <b>1</b>(1): 54–63. <a target=xrefwindow id=d22327e1470 href="http://www.ncbi.nlm.nih.gov/pubmed/24416729">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1473 href="http://dx.doi.org/10.1158/2326-6066.CIR-13-0034">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1477 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885978">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726502160"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1486 class=n-a></a>Zaretsky JM, Garcia-Diaz A, Shin DS, <i> et al.</i>: Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. <i>N Engl J Med.</i> 2016; <b>375</b>(9): 819–29. <a target=xrefwindow id=d22327e1497 href="http://www.ncbi.nlm.nih.gov/pubmed/27433843">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1500 href="http://dx.doi.org/10.1056/NEJMoa1604958">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1504 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007206">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726502160">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1047827"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1517 class=n-a></a>Galon J, Costes A, Sanchez-Cabo F, <i> et al.</i>: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. <i>Science.</i> 2006; <b>313</b>(5795): 1960–4. <a target=xrefwindow id=d22327e1528 href="http://www.ncbi.nlm.nih.gov/pubmed/17008531">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1531 href="http://dx.doi.org/10.1126/science.1129139">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1047827">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d22327e1545 class=n-a></a>Fridman WH, Pages F, Sautes-Fridman C, <i> et al.</i>: The immune contexture in human tumours: impact on clinical outcome. <i>Nat Rev Cancer.</i> 2012; <b>12</b>(4): 298–306. <a target=xrefwindow id=d22327e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/22419253">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1559 href="http://dx.doi.org/10.1038/nrc3245">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725249074"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1568 class=n-a></a>Tumeh PC, Harview CL, Yearley JH, <i> et al.</i>: PD-1 blockade induces responses by inhibiting adaptive immune resistance. <i>Nature.</i> 2014; <b>515</b>(7528): 568–71. <a target=xrefwindow id=d22327e1579 href="http://www.ncbi.nlm.nih.gov/pubmed/25428505">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1582 href="http://dx.doi.org/10.1038/nature13954">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1586 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246418">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725249074">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d22327e1599 class=n-a></a>Brahmer JR, Drake CG, Wollner I, <i> et al.</i>: Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. <i>J Clin Oncol.</i> 2010; <b>28</b>(19): 3167–75. <a target=xrefwindow id=d22327e1610 href="http://www.ncbi.nlm.nih.gov/pubmed/20516446">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1613 href="http://dx.doi.org/10.1200/JCO.2009.26.7609">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1617 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834717">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d22327e1626 class=n-a></a>Postow MA, Chasalow SD, Yuan J, <i> et al.</i>: Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg). <i>J Clin Oncol.</i> 2012; <b>30</b>(Suppl): abstract 8575. <a target=xrefwindow id=d22327e1637 href="http://meetinglibrary.asco.org/content/98956-114">Reference Source</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d22327e1646 class=n-a></a>Ku GY, Yuan J, Page DB, <i> et al.</i>: Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival. <i>Cancer.</i> 2010; <b>116</b>(7): 1767–75. <a target=xrefwindow id=d22327e1657 href="http://www.ncbi.nlm.nih.gov/pubmed/20143434">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1660 href="http://dx.doi.org/10.1002/cncr.24951">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1664 href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917065">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718880272"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1673 class=n-a></a>Kvistborg P, Philips D, Kelderman S, <i> et al.</i>: Anti-CTLA-4 therapy broadens the melanoma-reactive CD8<sup>+</sup> T cell response. <i>Sci Transl Med.</i> 2014; <b>6</b>(254): 254ra128. <a target=xrefwindow id=d22327e1687 href="http://www.ncbi.nlm.nih.gov/pubmed/25232180">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1691 href="http://dx.doi.org/10.1126/scitranslmed.3008918">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718880272">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d22327e1705 class=n-a></a>Chen H, Liakou CI, Kamat A, <i> et al.</i>: Anti-CTLA-4 therapy results in higher CD4<sup>+</sup>ICOS<sup>hi</sup> T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues. <i>Proc Natl Acad Sci U S A.</i> 2009; <b>106</b>(8): 2729–34. <a target=xrefwindow id=d22327e1723 href="http://www.ncbi.nlm.nih.gov/pubmed/19202079">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1726 href="http://dx.doi.org/10.1073/pnas.0813175106">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1729 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2650334">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1123075"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1738 class=n-a></a>Liakou CI, Kamat A, Tang DN, <i> et al.</i>: CTLA-4 blockade increases IFNgamma-producing CD4<sup>+</sup>ICOS<sup>hi</sup> cells to shift the ratio of effector to regulatory T cells in cancer patients. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(39): 14987–92. <a target=xrefwindow id=d22327e1756 href="http://www.ncbi.nlm.nih.gov/pubmed/18818309">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1759 href="http://dx.doi.org/10.1073/pnas.0806075105">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1762 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2567480">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1123075">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d22327e1775 class=n-a></a>Harlin H, Meng Y, Peterson AC, <i> et al.</i>: Chemokine expression in melanoma metastases associated with CD8<sup>+</sup> T-cell recruitment. <i>Cancer Res.</i> 2009; <b>69</b>(7): 3077–85. <a target=xrefwindow id=d22327e1789 href="http://www.ncbi.nlm.nih.gov/pubmed/19293190">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1793 href="http://dx.doi.org/10.1158/0008-5472.CAN-08-2281">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3886718">Free Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725587207"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1805 class=n-a></a>Mikucki ME, Fisher DT, Matsuzaki J, <i> et al.</i>: Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. <i>Nat Commun.</i> 2015; <b>6</b>(7458): 7458. <a target=xrefwindow id=d22327e1816 href="http://www.ncbi.nlm.nih.gov/pubmed/26109379">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1819 href="http://dx.doi.org/10.1038/ncomms8458">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1823 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4605273">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725587207">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d22327e1836 class=n-a></a>Fuertes MB, Woo SR, Burnett B, <i> et al.</i>: Type I interferon response and innate immune sensing of cancer. <i>Trends Immunol.</i> 2013; <b>34</b>(2): 67–73. <a target=xrefwindow id=d22327e1847 href="http://www.ncbi.nlm.nih.gov/pubmed/23122052">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1850 href="http://dx.doi.org/10.1016/j.it.2012.10.004">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1854 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3565059">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d22327e1863 class=n-a></a>Pestka S, Krause CD, Walter MR: Interferons, interferon-like cytokines, and their receptors. <i>Immunol Rev.</i> 2004; <b>202</b>(1): 8–32. <a target=xrefwindow id=d22327e1871 href="http://www.ncbi.nlm.nih.gov/pubmed/15546383">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1874 href="http://dx.doi.org/10.1111/j.0105-2896.2004.00204.x">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725755008"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1884 class=n-a></a>Chiappinelli KB, Strissel PL, Desrichard A, <i> et al.</i>: Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. <i>Cell.</i> 2015; <b>162</b>(5): 974–86. <a target=xrefwindow id=d22327e1895 href="http://www.ncbi.nlm.nih.gov/pubmed/26317466">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1898 href="http://dx.doi.org/10.1016/j.cell.2015.07.011">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1902 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4556003">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725755008">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d22327e1915 class=n-a></a>Spranger S, Spaapen RM, Zha Y, <i> et al.</i>: Up-regulation of PD-L1, IDO and T<sub>regs</sub> in the melanoma tumor microenvironment is driven by CD8<sup>+</sup> T cells. <i>Sci Transl Med.</i> 2013; <b>5</b>(200): 200ra116. <a target=xrefwindow id=d22327e1933 href="http://www.ncbi.nlm.nih.gov/pubmed/23986400">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1936 href="http://dx.doi.org/10.1126/scitranslmed.3006504">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1939 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4136707">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d22327e1948 class=n-a></a>Taube JM, Anders RA, Young GD, <i> et al.</i>: Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape. <i>Sci Transl Med.</i> 2012; <b>4</b>(127): 127ra37. <a target=xrefwindow id=d22327e1959 href="http://www.ncbi.nlm.nih.gov/pubmed/22461641">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1962 href="http://dx.doi.org/10.1126/scitranslmed.3003689">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1966 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3568523">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725749073"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e1975 class=n-a></a>Schmidt LH, Kümmel A, Görlich D, <i> et al.</i>: PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. <i>PLoS One.</i> 2015; <b>10</b>(8): e0136023. <a target=xrefwindow id=d22327e1986 href="http://www.ncbi.nlm.nih.gov/pubmed/26313362">PubMed Abstract </a> | <a target=xrefwindow id=d22327e1989 href="http://dx.doi.org/10.1371/journal.pone.0136023">Publisher Full Text </a> | <a target=xrefwindow id=d22327e1993 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4552388">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725749073">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718319306"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2006 class=n-a></a>Schalper KA, Velcheti V, Carvajal D, <i> et al.</i>: <i>In situ</i> tumor PD-L1 mRNA expression is associated with increased TILs and better outcome in breast carcinomas. <i>Clin Cancer Res.</i> 2014; <b>20</b>(10): 2773–82. <a target=xrefwindow id=d22327e2020 href="http://www.ncbi.nlm.nih.gov/pubmed/24647569">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2024 href="http://dx.doi.org/10.1158/1078-0432.CCR-13-2702">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718319306">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718131381"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2037 class=n-a></a>Ott PA, Hodi FS, Robert C: CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. <i>Clin Cancer Res.</i> 2013; <b>19</b>(19): 5300–9. <a target=xrefwindow id=d22327e2045 href="http://www.ncbi.nlm.nih.gov/pubmed/24089443">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2048 href="http://dx.doi.org/10.1158/1078-0432.CCR-13-0143">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718131381">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/717548111"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2062 class=n-a></a>Topalian SL, Hodi FS, Brahmer JR, <i> et al.</i>: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. <i>N Engl J Med.</i> 2012; <b>366</b>(26): 2443–54. <a target=xrefwindow id=d22327e2073 href="http://www.ncbi.nlm.nih.gov/pubmed/22658127">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2076 href="http://dx.doi.org/10.1056/NEJMoa1200690">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2080 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3544539">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/717548111">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718770930"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2093 class=n-a></a>Parsa AT, Waldron JS, Panner A, <i> et al.</i>: Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. <i>Nat Med.</i> 2007; <b>13</b>(1): 84–8. <a target=xrefwindow id=d22327e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/17159987">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2107 href="http://dx.doi.org/10.1038/nm1517">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718770930">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725265551"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2120 class=n-a></a>Madore J, Vilain RE, Menzies AM, <i> et al.</i>: PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials. <i>Pigment Cell Melanoma Res.</i> 2015; <b>28</b>(3): 245–53. <a target=xrefwindow id=d22327e2131 href="http://www.ncbi.nlm.nih.gov/pubmed/25477049">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2134 href="http://dx.doi.org/10.1111/pcmr.12340">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725265551">F1000 Recommendation</a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718408779"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2147 class=n-a></a>Highfill SL, Cui Y, Giles AJ, <i> et al.</i>: Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy. <i>Sci Transl Med.</i> 2014; <b>6</b>(237): 237ra67. <a target=xrefwindow id=d22327e2158 href="http://www.ncbi.nlm.nih.gov/pubmed/24848257">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2161 href="http://dx.doi.org/10.1126/scitranslmed.3007974">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718408779">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1164118"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2174 class=n-a></a>Peggs KS, Quezada SA, Chambers CA, <i> et al.</i>: Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. <i>J Exp Med.</i> 2009; <b>206</b>(8): 1717–25. <a target=xrefwindow id=d22327e2185 href="http://www.ncbi.nlm.nih.gov/pubmed/19581407">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2188 href="http://dx.doi.org/10.1084/jem.20082492">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2192 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2722174">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1164118">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718049974"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2205 class=n-a></a>Simpson TR, Li F, Montalvo-Ortiz W, <i> et al.</i>: Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. <i>J Exp Med.</i> 2013; <b>210</b>(9): 1695–710. <a target=xrefwindow id=d22327e2216 href="http://www.ncbi.nlm.nih.gov/pubmed/23897981">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2219 href="http://dx.doi.org/10.1084/jem.20130579">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2223 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3754863">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718049974">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d22327e2237 class=n-a></a>Hooper LV, Littman DR, Macpherson AJ: Interactions between the microbiota and the immune system. <i>Science.</i> 2012; <b>336</b>(6086): 1268–73. <a target=xrefwindow id=d22327e2245 href="http://www.ncbi.nlm.nih.gov/pubmed/22674334">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2248 href="http://dx.doi.org/10.1126/science.1223490">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2251 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4420145">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/717955892"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2260 class=n-a></a>Abt MC, Osborne LC, Monticelli LA, <i> et al.</i>: Commensal bacteria calibrate the activation threshold of innate antiviral immunity. <i>Immunity.</i> 2012; <b>37</b>(1): 158–70. <a target=xrefwindow id=d22327e2271 href="http://www.ncbi.nlm.nih.gov/pubmed/22705104">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2274 href="http://dx.doi.org/10.1016/j.immuni.2012.04.011">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2278 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3679670">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/717955892">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725917835"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2291 class=n-a></a>Sivan A, Corrales L, Hubert N, <i> et al.</i>: Commensal <i>Bifidobacterium</i> promotes antitumor immunity and facilitates anti-PD-L1 efficacy. <i>Science.</i> 2015; <b>350</b>(6264): 1084–9. <a target=xrefwindow id=d22327e2305 href="http://www.ncbi.nlm.nih.gov/pubmed/26541606">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2309 href="http://dx.doi.org/10.1126/science.aac4255">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2312 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4873287">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725917835">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d22327e2325 class=n-a></a>Xue W, Zender L, Miething C, <i> et al.</i>: Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. <i>Nature.</i> 2007; <b>445</b>(7128): 656–60. <a target=xrefwindow id=d22327e2336 href="http://www.ncbi.nlm.nih.gov/pubmed/17251933">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2339 href="http://dx.doi.org/10.1038/nature05529">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2343 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4601097">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d22327e2352 class=n-a></a>Iannello A, Thompson TW, Ardolino M, <i> et al.</i>: p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. <i>J Exp Med.</i> 2013; <b>210</b>(10): 2057–69. <a target=xrefwindow id=d22327e2363 href="http://www.ncbi.nlm.nih.gov/pubmed/24043758">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2366 href="http://dx.doi.org/10.1084/jem.20130783">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2370 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3782044">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726210134"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2379 class=n-a></a>Madore J, Strbenac D, Vilain R, <i> et al.</i>: PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma. <i>Clin Cancer Res.</i> 2016; <b>22</b>(15): 3915–23. <a target=xrefwindow id=d22327e2390 href="http://www.ncbi.nlm.nih.gov/pubmed/26960397">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2393 href="http://dx.doi.org/10.1158/1078-0432.CCR-15-1714">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726210134">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726826430"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2407 class=n-a></a>Shin D, Garcia-Diaz A, Zaretsky J, <i> et al.</i>: Innate resistance of PD-1 blockade through loss of function mutations in JAK resulting in inability to express PD-L1 upon interferon exposure. <i>J Immunother Cancer.</i> 2015; <b>3</b>(Suppl 2): P311. <a target=xrefwindow id=d22327e2418 href="http://dx.doi.org/10.1186/2051-1426-3-S2-P311">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2421 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4649399">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726826430">F1000 Recommendation</a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726074850"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2434 class=n-a></a>Ikeda S, Okamoto T, Okano S, <i> et al.</i>: PD-L1 Is Upregulated by Simultaneous Amplification of the <i>PD-L1</i> and <i>JAK2</i> Genes in Non-Small Cell Lung Cancer. <i>J Thorac Oncol.</i> 2016; <b>11</b>(1): 62–71. <a target=xrefwindow id=d22327e2452 href="http://www.ncbi.nlm.nih.gov/pubmed/26762740">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2455 href="http://dx.doi.org/10.1016/j.jtho.2015.09.010">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726074850">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726000752"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2468 class=n-a></a>Peng W, Chen JQ, Liu C, <i> et al.</i>: Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy. <i>Cancer Discov.</i> 2016; <b>6</b>(2): 202–16. <a target=xrefwindow id=d22327e2479 href="http://www.ncbi.nlm.nih.gov/pubmed/26645196">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2482 href="http://dx.doi.org/10.1158/2159-8290.CD-15-0283">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2486 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4744499">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726000752">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d22327e2499 class=n-a></a>Marzec M, Zhang Q, Goradia A, <i> et al.</i>: Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(52): 20852–7. <a target=xrefwindow id=d22327e2510 href="http://www.ncbi.nlm.nih.gov/pubmed/19088198">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2513 href="http://dx.doi.org/10.1073/pnas.0810958105">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2517 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2634900">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d22327e2526 class=n-a></a>Garon EB, Rizvi NA, Hui R, <i> et al.</i>: Pembrolizumab for the treatment of non-small-cell lung cancer. <i>N Engl J Med.</i> 2015; <b>372</b>(21): 2018–28. <a target=xrefwindow id=d22327e2537 href="http://www.ncbi.nlm.nih.gov/pubmed/25891174">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2540 href="http://dx.doi.org/10.1056/NEJMoa1501824">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725495968"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2549 class=n-a></a>Spranger S, Bao R, Gajewski TF: Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. <i>Nature.</i> 2015; <b>523</b>(7559): 231–5. <a target=xrefwindow id=d22327e2557 href="http://www.ncbi.nlm.nih.gov/pubmed/25970248">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2560 href="http://dx.doi.org/10.1038/nature14404">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725495968">F1000 Recommendation</a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13296997"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2574 class=n-a></a>Fuertes MB, Kacha AK, Kline J, <i> et al.</i>: Host type I IFN signals are required for antitumor CD8<sup>+</sup> T cell responses through CD8{alpha}+ dendritic cells. <i>J Exp Med.</i> 2011; <b>208</b>(10): 2005–16. <a target=xrefwindow id=d22327e2588 href="http://www.ncbi.nlm.nih.gov/pubmed/21930765">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2592 href="http://dx.doi.org/10.1084/jem.20101159">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2595 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3182064">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13296997">F1000 Recommendation</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726029300"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2608 class=n-a></a>Van Lint S, Renmans D, Broos K, <i> et al.</i>: Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells. <i>Cancer Immunol Res.</i> 2016; <b>4</b>(2): 146–56. <a target=xrefwindow id=d22327e2619 href="http://www.ncbi.nlm.nih.gov/pubmed/26659303">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2622 href="http://dx.doi.org/10.1158/2326-6066.CIR-15-0163">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726029300">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725437319"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2635 class=n-a></a>Fu J, Kanne DB, Leong M, <i> et al.</i>: STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. <i>Sci Transl Med.</i> 2015; <b>7</b>(283): 283ra52. <a target=xrefwindow id=d22327e2646 href="http://www.ncbi.nlm.nih.gov/pubmed/25877890">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2649 href="http://dx.doi.org/10.1126/scitranslmed.aaa4306">Publisher Full Text </a> | <a target=xrefwindow id=d22327e2653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4504692">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725437319">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726414991"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d22327e2666 class=n-a></a>Blank CU, Haanen JB, Ribas A, <i> et al.</i>: CANCER IMMUNOLOGY. The “cancer immunogram”. <i>Science.</i> 2016; <b>352</b>(6286): 658–60. <a target=xrefwindow id=d22327e2677 href="http://www.ncbi.nlm.nih.gov/pubmed/27151852">PubMed Abstract </a> | <a target=xrefwindow id=d22327e2680 href="http://dx.doi.org/10.1126/science.aaf2834">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726414991">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Oct 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2545/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2545/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Melanoma/Sarcoma Group, Oncology Center, Hospital S&iacute;rio Liban&ecirc;s, S&atilde;o Paulo, Brazil<br/> <sup>2</sup> Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA<br/> <sup>3</sup> Weill Cornell Medical College, New York, NY, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/5-2545/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 20 Oct 2016, 5:2545 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.9356.1">https://doi.org/10.12688/f1000research.9356.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2016 Munhoz RR and Postow MA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=10074 data-id=9356 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9356.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/5-2545/v1/pdf?article_uuid=1a9746b7-3d3c-4874-a1fd-ec5589474bc1" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.9356.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Munhoz RR and Postow MA. Recent advances in understanding antitumor immunity [version 1; peer review: 3 approved] <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2545 (<a href="https://doi.org/10.12688/f1000research.9356.1" target=_blank>https://doi.org/10.12688/f1000research.9356.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=9356 id=mobile-track-article-signin-9356 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9356?target=/articles/5-2545/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10074 /> <input name=articleId type=hidden value=9356 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Karine Breckpot</strong>, Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Belgium </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Timothy M Illidge</strong>, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Daniel Speiser</strong>, Department of Oncology, Ludwig Center for Cancer Research, University of Lausanne, Switzerland </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 20 Oct 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2545/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2545/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=17732-17128></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=17734-17129></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=17733-17130></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/5-2545/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>20 Oct 16</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Karine Breckpot</strong>, Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Belgium </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Timothy M Illidge</strong>, Division of Molecular and Clinical Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Daniel Speiser</strong>, Department of Oncology, Ludwig Center for Cancer Research, University of Lausanne, Switzerland </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/5-2545/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/5-2545/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding antitumor...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/5-2545/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/5-2545/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/5-2545/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Munhoz RR and Postow MA');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/5-2545/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/5-2545",
            templates : {
                twitter : "Recent advances in understanding antitumor immunity. Munhoz RR and Postow MA, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/5-2545/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding antitumor immunity", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding antitumor immunity", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/9356/10074")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "10074");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "17128": 1,
                           "17129": 0,
                           "17130": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "d081cf51-aa6d-412e-8aab-89bdb391f956";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2545.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2545.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2545.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/5-2545.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/5-2545.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>